Connect with us

Trending News

AP Corrects Ivermectin Fake News — Only 2% Poison Control Calls, Not 70% .

Justin Malonson



The Associated Press issued a correction to a story last month that claimed a hospital in Mississippi was inundated with patients who overdosed on Ivermectin.

In the article from August 24, titled, “Livestock medicine doesn’t work against COVID, doctors warn,” the AP falsely reported that 70 percent of Mississippi’s poison control calls were related to Ivermectin.

But the prestigious media organization had major egg on its face when an update issued two days later admitted their original reporting was off by around 3,400 percent.

A similar amendment was made to the original story, the contents of which was edited.

The error was so egregious it went out as its own separate headline, distributed among innumerable Associated Press syndicates.

The monumental blunder was blamed on the Mississippi Department of Health misreporting its figures.

Despite the correction nearly derailing the story’s entire premise, no other edits were made to the article which attempted to demonize the effectiveness of the anti-parasitic drug.

The AP’s correction preceded news that podcast host Joe Rogan had taken Ivermectin as a treatment after contracting Covid-19. Two days later, he was healthy as a horse.

Similarly, Rolling Stone magazine was recently forced to issue an update on a popular story which claimed Oklahoma hospitals were overwhelmed with patients who overdosed on Ivermectin. The hospital network in question released a statement refuting reporting from local media and other media outlets.

Meanwhile, Tokyo, Japan’s top medical official Dr. Haruo Ozaki has urged widespread use of the drug in the population, citing major statistics it works as a preventative treatment.

Follow the author on Gab:





Justin Malonson is a successful author, investigative reporter and the host of the Freedom Not Control Radio Show. As a serial entrepreneur with a strong background in software development Justin is one of the most highly sought-after tech entrepreneurs today.

Copyright © 2021 Federal Inquirer. All rights reserved.